GGrantIndex
← Search

Proteomics Core

$2,608P30FY2018CANIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications, trials & patents

Trial NCT06508463Trial NCT06387979Trial NCT06381154Trial NCT06353191Trial NCT06315595Trial NCT06271291Trial NCT06238648Trial NCT06207188Trial NCT06160206Trial NCT06115772Trial NCT06078709Trial NCT06075524Trial NCT06073951Trial NCT06058663Trial NCT05917145Trial NCT05910801Trial NCT05720624Trial NCT05717153Trial NCT05704283Trial NCT05703399Trial NCT05674123Trial NCT05653661Trial NCT05640765Trial NCT05612100Trial NCT05591092Trial NCT05584449Trial NCT05575440Trial NCT05560009Trial NCT05557877Trial NCT05556525Trial NCT05549661Trial NCT05547386Trial NCT05547347Trial NCT05541016Trial NCT05530759Trial NCT05526417Trial NCT05523154Trial NCT05518903Trial NCT05512767Trial NCT05507879Trial NCT05507541Trial NCT05497804Trial NCT05465954Trial NCT05465941Trial NCT05447923Trial NCT05447910Trial NCT05443971Trial NCT05438563Trial NCT05417867Trial NCT05416983Trial NCT05412953Trial NCT05411523Trial NCT05411497Trial NCT05410977Trial NCT05407038Trial NCT05407025Trial NCT05403580Trial NCT05399004Trial NCT05393713Trial NCT05392946Trial NCT05388877Trial NCT05388851Trial NCT05388058Trial NCT05388006Trial NCT05356897Trial NCT05294367Trial NCT05288062Trial NCT05269381Trial NCT05246670Trial NCT05232851Trial NCT05224271Trial NCT05222620Trial NCT05212428Trial NCT05199285Trial NCT05194293Trial NCT05176223Trial NCT05168163Trial NCT05130060Trial NCT05112627Trial NCT05112614Trial NCT05111314Trial NCT05077735Trial NCT05075980Trial NCT05053100Trial NCT05045066Trial NCT05033288Trial NCT05030298Trial NCT05018208Trial NCT05005182Trial NCT04999826Trial NCT04975516Trial NCT04967196Trial NCT04926948Trial NCT04925817Trial NCT04917744Trial NCT04906369Trial NCT04897009Trial NCT04895735Trial NCT04892277Trial NCT04892264

Abstract

For over twenty years the goal of the Proteomics Core (PC) has been to provide essential services in protein chemistry, protein separation and mass spectrometry to center members fostering many investigations in proteomics and clinical biomarker discovery. From 2008-2012, the PC has supported 102 cancer center members with a broad diversity of projects in ten MCCC programs that include Cell Biology, Developmental Therapeutics, Gene and Virus Therapy, Cancer Immunology and Immunotherapy, Gastrointestinal Cancer, Hematologic Malignancies, Neuro-onclogy, Women's Cancer and others. These investigators are members of 31 departments or divisions at Mayo Clinic; between 2010-2012 over 72% of these members had active peer-reviewed funding. Since the analysis, separation, and characterization of proteins or protein-protein complexes is an essential aspect of many cancer-related investigations and translational discoveries, the PC offers a broad variety of services to support protein analysis. These services are divided into six major categories:(1) Peptide Synthesis Services; (2) Mass Spectrometry Services; (3) Protein and Peptide Separation Services; (4) Quantitative Services: Peptide or Small Molecule; (5) Electrophoresis Services; and (6) Ancillary and Computational Services. The services offered are highly competitive with outside vendors and academic institutions and they are readily accessible via web ordering or by personal request; the ease of in-house access and the fast turn-around time for most services provides great value to center members. Dr. McCormick has been director of the shared resource since 1992, and Dr. Bergen the co-director since 2005. Their effective vision and direction of the 10.4 FTE technical staff has produced a high level of productivity, service, and value to cancer center members. Center members have first priority access to all services and obtain free consultation and project management; in general the resource offers a fee-for-service users via a charge back system. In the currently funded period (2012-2013) fifty-four (54) center members utilized 2468 units of service, which comprised a 64% total usage of all services offered by the PC shared resource; of these fifty-four members, 72% (i.e. 39 members) had peer reviewed support, and 28% (i.e., 15 members) were unfunded: (Note: many of the unfunded members were either junior faculty or new recruits).

View original record on NIH RePORTER →